StayCurrentMD · Routing Kinetics of Human Immunoglobulin-G after Transamniotic Fetal Immunotherapy (TRAFIT) in a Rodent Model
Article1 min read·Published Feb 2022Older

Routing Kinetics of Human Immunoglobulin-G after Transamniotic Fetal Immunotherapy (TRAFIT) in a Rodent Model

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Feb 2022 · 1 min read

In brief

In brief

Experimental study investigating the absorption pathways of human IgG after intra-amniotic injection in a rat model, tracking distribution across fetal tissues and fluids over three gestational timepoints. Research aims to elucidate mechanisms underlying transamniotic fetal immunotherapy, a minimally invasive approach for prenatal immunoglobulin delivery.

Written by the GCMD Library team from the article.

Abstract

Purpose

The transamniotic route was recently discovered as a minimally invasive means of fetal immunoglobulin administration, however by unclear mechanisms. We sought to examine IgG routing after intra-amniotic delivery.

Methods

Sprague-Dawley fetuses (n=78) received intra-amniotic injections of 15mg/mL of human IgG on gestational-day 18 (E18; term=21-22 days). Amniotic fluid, amnion, chorion, placenta, fetal serum, liver, and stomach-aspirate samples were procured on E19, E20, and E21 for IgG quantification by ELISA. Statistical analysis was by median regression with Bonferroni-adjusted significance at p

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →